-Business Standard Unlikely to rise further as the government allowed imports, release stock held by Nafed Mumbai: With its price shot up sharply in the last few weeks, tur dal has started slipping out of consumers’ plate steadily. Data compiled by the Union Ministry of Food, Consumer Affairs and Public Distribution showed the maximum tur dal prices across the country is at Rs 110 a kg on higher side and average or model...

-The Times of India CHENNAI: In a major step to make cancer cure affordable for patients and their families, the retail prices of several anti-cancer drugs, including commonly used chemotherapy injections for lung cancer treatment, have been slashed by up to 87% by the drug price control authority. After reviewing the data collected from drug manufacturers, the National Pharmaceutical Pricing Authority’s May 15 memorandum has brought nine anti-cancer drugs in its price...

-The Telegraph Call to govt to adopt 'cost-based' control The 30 per cent cap on profit margins imposed by India’s drug pricing authority on 42 anti-cancer drugs will have a limited impact on patients’ expenses because many of these medicines’ prices remain “prohibitive”, a network of patients’ rights groups said on Saturday. The All India Drug Action Network (Aidan) said the National Pharmaceutical Pricing Authority’s cap on profit margins in effect “legitimises” the...

-The Hindu The falling Indian rupee will make oil imports costlier and lead to a rise in fuel prices Mumbai: After holding on for a day, the State-owned oil marketing companies (OMCs) again increased the price of petroleum products such as petrol and diesel in the country on Thursday. The prices of petrol and diesel touched a new high on Thursday with Mumbai paying the maximum among the four metros. While petrol costs...

-The Times of India NEW DELHI: Even as stent prices have been capped, the cost of the three main consumables used in angioplasty have, in many cases, become even more expensive than stents as hospitals try to make up for the huge margins they lost on stents. The modus operandi is same as in the case of stents before the price cap. Though the consumables are bought at a third or less...